Lifecycle management of single use technologies
05th March 2019 | 2 PM CET | Francis Verhoeye, Director Single Use Technologies, GSK Vaccines |BOOK FREE SEAT
Single-use technologies (SUTs) are one of the key drivers in the biopharmaceutical industry today and are changing the way we are operating and qualifying our bioprocesses, offering more flexibility and increasing efficiency. However, the extended use of those technologies in commercial operations requires a robust and specific lifecycle management approach. In this context, we have built an improved technical lifecycle management approach involving close partnership with key suppliers, enhanced standardization, early involvement of global manufacturing functions and full compliance with item creation process in order to ensure business continuity and value creation.
Presented by Francis Verhoeye, Director Single Use Technologies, GSK Vaccines
Francis Verhoeye serves as Director Single Use Technologies at GSK Vaccines and is responsible for the technical integration and lifecycle management of single use systems in the Global Industrial Operations. Francis started his professional career in the field of pharmacology and bioengineering at the University of Louvain in Belgium. He benefits from more than 15 years operational experience in the field of animal and human cell culture techniques, upstream development and scale up as well as technology transfer management and disposable solutions implementation (management positions held at Novasep, LFB Biotechnologies, Cardio3 Biosciences and Zoetis). Francis holds a PhD in Biology and a complementary degree in Management from the University of Louvain, Belgium.